IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹738 Cr | ₹547 Cr | ₹471 Cr | ₹884 Cr | ₹1,140 Cr |
What is the latest Consolidated Net Profit of IPCA LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹738 Cr |
| Mar2025 | ₹547 Cr |
| Mar2024 | ₹471 Cr |
| Mar2023 | ₹884 Cr |
| Mar2022 | ₹1,140 Cr |
How is Consolidated Net Profit of IPCA LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹738 Cr | 34.77 | |
| Mar2025 | ₹547 Cr | 16.13 | |
| Mar2024 | ₹471 Cr | -46.69 | |
| Mar2023 | ₹884 Cr | -22.45 | |
| Mar2022 | ₹1,140 Cr | - | |
Compare Consolidated Net Profit of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,723.9 Cr | -0.3% | 0.7% | 48.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -0.3% |
0.7% |
48.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses